does ghk-cu really work Work? 40 Years of Research Reviewed Injectable Peptides for Anti-Aging? A

Even tho i cannot 100% say for sure that BPC-157 was the reason that both treated areas are now feeling better after the therapy I can with certainty say that i did not experience any systemic healing effects on untreated areas that are now exhibiting similar symptoms

The full-length Thymosin Beta-4 has been investigated in clinical trials by RegeneRx for indications including epidermolysis bullosa, dry eye, and pressure ulcers none of which has resulted in approved use

Dosages can vary depending on the health concern

Current research on BPC-157 is shown in the table below

Crucially, the side effect profile of NAD+ largely depends on dosage and infusion rate

Safety and Side Effects BPC 157 is not approved by major regulatory bodies like the FDA, and long-term safety data in humans is limited